⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9715235 | 1.00 | — | — | |
| SCHEMBL1490201 | 0.94 | — | — | |
| Iodide SCHEMBL22607735 | 0.73 | — | — | |
| SCHEMBL3929943 | 0.72 | — | — | |
| SCHEMBL13635797 | 0.69 | — | — | |
| SCHEMBL2803767 | 0.64 | — | — | |
| SCHEMBL11069121 | 0.59 | — | — | |
| SCHEMBL30420459 | 0.59 | — | — | |
| SCHEMBL11069118 | 0.59 | — | — | |
| SCHEMBL29666134 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111440633-B | Mesophase pitch and preparation method and application thereof | 湖南东映长联科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20250011330-A1 | Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors | LEIDOS BIOMEDICAL RESEARCH INC. | 2025-01-09 | — | — | US | disclosed |
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | KETONEX LIMITED (GB) | 2019-10-22 | — | — | US | disclosed |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | OXFORD PERFORMANCE MATERIALS, INC | 2017-09-07 | — | — | US | disclosed |
| EP-2266792-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | Asahi Glass Company, Limited (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7847119-B2 | Drug conjugates | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2010-12-07 | — | — | US | disclosed |
| US-20100047661-A1 | POLYMER LAMINATE MEMBRANE, THE METHOD FOR PRODUCING THE MEMBRANE AND THE USE OF THE MEMBRANE | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-02-25 | — | — | US | disclosed |
| US-7638220-B2 | Polymeric laminates, processes for producing the same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20080139815-A1 | DRUG CONJUGATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-06-12 | — | — | US | disclosed |
| US-7285616-B2 | Aromatic polymer, method for producing the same and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7282590-B2 | Selectively target tumor cells with highly potent cytotoxic drugs at a drug release rate that is effective for the destruction and/or inhibition of tumor cells | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2007-10-16 | — | — | US | disclosed |
| EP-1718335-A2 | DRUG CONJUGATES | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2006-11-08 | — | — | EP | disclosed |
| US-20050232928-A1 | Drug conjugates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-10-20 | — | — | US | disclosed |
| WO-2005079398-A2 | DRUG CONJUGATES | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2005-09-01 | — | — | WO | disclosed |